Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: a network meta-analysis

Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: a network meta-analysis

This study aimed to conduct a network meta-analysis (NMA) to compare the efficacy of brain natriuretic peptide (BNP) vs nicorandil for preventing contrast-induced nephropathy (CIN). Databases of Pubmed, Cochrane, Embase, Web of Science were searched by keywords for eligible studies of randomized con...

Full description

Bibliographic Details
Main Authors:	Ziwei Mei, Songmei Luo, Peipei Chen, Qiankun Zhang, Limei Zhou, Chaoyong Zhu, Hong Zhu, Lie Jin
Format:	Article
Language:	English
Published:	PeerJ Inc. 2022-02-01
Series:	PeerJ
Subjects:	Contrast-induced nephropathy Brain natriuretic peptide Nicorandil Meta-analysis
Online Access:	https://peerj.com/articles/12975.pdf

Similar Items

From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides
by: Wei Fong Ang, et al.
Published: (2022-09-01)

The Natriuretic Peptide System: A Single Entity, Pleiotropic Effects
by: Vittoriano Della Corte, et al.
Published: (2023-06-01)

Modified natriuretic peptides and their potential roles in cancer treatment
by: Mengjiao Xu, et al.
Published: (2022-02-01)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
by: Pâmela Nogueira Cavalcante, et al.
Published: (2023-09-01)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
by: Simone Vink, et al.
Published: (2023-03-01)

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease
by: Zohreh Khaki, et al.
Published: (2022-12-01)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
by: Pang-Yen Liu, et al.
Published: (2023-08-01)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
by: Max Lenz, et al.
Published: (2021-01-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Associations of atrial natriuretic peptide with measures of insulin and adipose depots
by: Catharine A. Couch, et al.
Published: (2023-03-01)

The level of Brain natriuretic Peptide as a Predictor of the Postoperative Period at Operations with Artificial Blood circulation
by: Yu. A. Bakhareva, et al.
Published: (2019-01-01)

Natriuretic peptide family. Options for use in outpatient practice
by: S. V. Ivanova, et al.
Published: (2014-12-01)

“CONTRAST” STUDY: COMPARİSİON OF NEPHROPROTECTİVE THREE PROTOCOLS: ACETYLCYSTEİNESODİUM BİCARBONATE-THEOPHYLLİNE, TO PREVENT CONTRAST-İNDUCED NEPHROPATHY
by: Ilker Murat Caglar, et al.
Published: (2014-01-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

Editorial: Contrast-induced nephropathy
by: Sinan Aydoğdu
Published: (2013-02-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms
by: Giovanna Gallo, et al.
Published: (2023-03-01)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
by: Hitoshi Nakagawa, et al.
Published: (2022-07-01)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
by: Riccardo Sarzani, et al.
Published: (2022-11-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathy
by: Deborah B. Diercks, et al.
Published: (2016-12-01)

ORAL TREATMENT WITH NICORANDIL AT DISCHARGE IS ASSOCIATED WITH REDUCED MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION
by: Y. Sakata, et al.
Published: (2012-10-01)

Mechanism of action and neuroprotective role of nicorandil in ischemic stroke
by: Maryam Owjfard, et al.
Published: (2024-02-01)

Value of mid-regional pro-atrial natriuretic peptide and brain natriuretic peptide for detection of acute heart failure in patients with dyspnea: diagnostic accuracy study
by: Kambiz Masoumi, et al.
Published: (2023-08-01)

Endocytosis and Trafficking of Natriuretic Peptide Receptor-A: Potential Role of Short Sequence Motifs
by: Kailash N. Pandey
Published: (2015-07-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer
by: Letizia Mezzasoma, et al.
Published: (2021-05-01)

N terminal prohormone of brain natriuretic peptide is associated with improved heart rate recovery after treadmill exercise test
by: Yi-Ting Lin, et al.
Published: (2023-09-01)

Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives
by: Dhirendra Singh, et al.
Published: (2024-04-01)

Comparison between Brain Natriuretic Peptide and Calcitonin Gene Related Peptide in Children with Dilated Cardiomyopathy
by: Noor Mohammad Noori, et al.
Published: (2017-09-01)

Amino-Terminal Pro-Brain Natriuretic Peptid in Prediction of Left Ventricular Ejection Fraction
by: Mugdim Bajrić, et al.
Published: (2008-08-01)

Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014-04-01)

Contrast-induced nephropathy: a review of literature
by: Roya Narenji Sani, et al.
Published: (2015-10-01)

Plasma Levels of Brain Natriuretic Peptides and Cardiac Troponin in Hemodialysis Patients
by: Halima Resić, et al.
Published: (2009-05-01)

Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01)

Experimental rat models for contrast-induced nephropathy; a comprehensive review
by: Marlon Perera, et al.
Published: (2020-04-01)

Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States
by: Tomoko Ichiki, et al.
Published: (2022-06-01)

Analysis of the B-Type Natriuretic Peptide and the Aminoterminal-Pro-B-Type Natriuretic Peptide in Different Parrot, Raptor and Owl Species
by: Anja Hennig, et al.
Published: (2022-02-01)

The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study)
by: Yu. V. Lukina, et al.
Published: (2022-09-01)

Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide (<i>nppcl</i>) Expression in Zebrafish (<i>Danio rerio</i>) Causes Stunted Growth during Development
by: Andrew J. Lessey, et al.
Published: (2023-08-01)